Washington Cancer Institute

Washington, District of Columbia 20010

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
Oncology Clinical Trial
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling, Phase II, III
Updated: 11/22/2016
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials